Prosiectau (365)
Cardiff University Schools involved in this Project
Agreement between the Wound Healing Research Unit and 3M Laboratories (Europe) Ltd - Skin Care Agreement (01.05.2001 - 30.11.2009)
- Harding, Keith
Acute Myeoild Leukaemia Trial (AML 15) Trial Grant (01.07.2002 - 31.12.2009)
- Burnett, Alan
AML 15 Trial Support Account (01.07.2002 - 31.07.2010)
- Burnett, Alan
Action on puerperal psychosis (01.11.2004 - 16.11.2011)
- Jones, Ian
All Wales Perinatal Survey (01.03.2005 - 31.03.2011)
- Kotecha, Sailesh
All Wales perinatal survey (01.04.2005 - 31.03.2011)
- Kotecha, Sailesh
Academic Fellowship Programme (01.09.2005 - 30.06.2011)
A population based study of young-onset and late onset Parkinson's disease (05.09.2005 - 31.10.2009)
A programme of treatment development for older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: Zarnestra (01.01.2006 - 31.12.2011)
- Burnett, Alan
A programme of treatment development of AML in older patients (01.02.2006 - 31.01.2013)
- Burnett, Alan
Analysis of the inhibitory effects of nitric oxide and cGMP on gap junctional communication and the EDHF phenomenon (26.06.2006 - 25.06.2009)
A phase II/III trial for older patients with acute myeloid leukaemia and high risk myelodysplastc syndrome: Intensive Arm - AML 16 (01.08.2006 - 30.06.2013)
- Hills, Robert
A trial for older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: Non-intensive arm (01.08.2006 - 30.06.2013)
- Burnett, Alan
A protocol for patients aged under 60 - AML 15 (18.09.2006 - 31.12.2009)
- Burnett, Alan
A programme of development for older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome - AML 16 (23.11.2006 - 31.12.2009)
- Burnett, Alan
Adolescent depression (01.12.2006 - 28.02.2010)
- Thapar, Anita
AML 16 A protocol for older patients with acute myeloid luekaemia and high risk myelodysplastic syndrome (01.12.2006 - 01.12.2011)
- Burnett, Alan
A psychological evaluation of familial ovarian cancer screening (01.01.2007 - 31.05.2012)
- Brain, Katherine
Arterial tree inflammation (01.03.2007 - 28.02.2017)
- Cockcroft, John
A randomised controlled trial of the effects of a web based PSA decision explorer, Prosdex (01.05.2007 - 31.07.2009)
Aetiology of gastroschisis: A prospective case control study to investigate the effects of lifestyle, dietary and environmental exposures (04.06.2007 - 28.02.2010)
- Paranjothy, Shantini
A clinical and genetic study of the unipolar-bipolar interface (01.07.2007 - 30.06.2010)
ABPI Research Fellowship (01.08.2007 - 31.07.2013)
- Routledge, Philip
Activity increase despite arthritis: Developing and evaluating an active management booklet for hip and knee pain (01.09.2007 - 31.12.2009)
Angiogenesis and anti-angiogenic approach in human cancer (01.10.2007 - 30.09.2011)
- Jiang, Wen
Anti-microbial peptides (01.12.2007 - 30.11.2008)
- Walsh, Timothy
A comparative study of behavioural and molecular changes in models of Huntington's disease (01.01.2008 - 31.12.2009)
- Jones, Aileen Lesley
A phase I/II trial of the mTOR inhibitor temsirolimus (CCI-779; torisel) plus gemcitabine and cisplatin as first-line therapy for metastatic bladder cancer (and other urothelial cell carcinomas) (TOTEM) (01.02.2008 - 31.12.2015)
Adults with learning disabilities and challenging behaviour: The costs and outcomes of in and out of area placements (01.04.2008 - 31.03.2010)
A multi-centre randomised phase 2 study of neoadjuvant chemotherapy followed by gemcitabine or cepecitabine based chemoradiotherapy for locally advanced nonmetastatic pancreatic cancer (SCALOP) (01.04.2008 - 31.01.2013)
An innovative multidisciplinary patient-centric early detection care model (01.04.2008 - 31.12.2009)
A phase II clinical trial on the reduction of meticillin resistant Staphylococcus Aureus in MRSA positive ulcers (01.04.2008 - 01.04.2011)
- Harding, Keith
Autocrine wnt signaling in human breast and ovarian cancer cells (01.06.2008 - 30.11.2011)
A 6 month prospective, randomized, double blind, placebo-controlled, parallel group, multiple centre trial to evaluate the efficacy and safety of fragmin in the treatment of chronic neuroischaemic foot ulcers in diabetic patients (17.06.2008 - 31.12.2010)
- Harding, Keith
AML17: A trial of development of the Myeloid Leukaemia and high risk Myelodysplastic Syndrome in younger patients (01.08.2008 - 31.07.2014)
- Burnett, Alan
A powerful, genome-wide association scan for susceptibility genes for late-onset Alzheimer's disease. (01.09.2008 - 28.02.2011)
- Williams, Julie
Assessment of floright to assist weaning from CPAP (01.09.2008 - 31.08.2010)
- Kotecha, Sailesh
A randomised controlled trial of larval therapy in the debridement of leg ulcers (01.10.2008 - 30.06.2012)
- Harding, Keith
A phase I-II study to evaluate the safety and toxicity and tolerability of NFkappaB inhibitor LC1 in the treatment of high risk haematological malignancies (03.11.2008 - 31.08.2013)
- Burnett, Alan
Assessing communication effects of re-engineering the clinical encounter space: a discourse analytic approach (10.11.2008 - 31.07.2009)
A study to determine the feasibility of molecular selection of therapy in patients with metastatic colorectal cancer (10.11.2008 - 09.11.2011)
A three-arm randomised control trial (01.12.2008 - 01.05.2010)
A combined neurophysiological and haemodynamic investigation of changes in functional connectivity in the human brain during sedation. (01.01.2009 - 01.01.2010)
- Hall, Judith
After mapping of Axilla, radiotherapy or surgery (01.01.2009 - 31.03.2010)
Artificially enhanced T-cells for targeting cancer (01.01.2009 - 01.01.2011)
- Cole, David
A lifecourse approach to healthy aging: Capitalizing on the value of UK lifecourse cohorts (01.02.2009 - 31.03.2013)
AML 17 being an acute myeloid leukaemia or high risk myelodysplastic syndrome multi-site randomised trial (01.02.2009 - 31.01.2012)
- Burnett, Alan
Assay methods for insulin analogues (01.02.2009 - 31.01.2011)
AML 17 A Randomised Clinical Trial for adults and children with Acute Myeloid Leukaemia or high risk Myelodysplastic syndrome (01.04.2009 - 31.07.2016)
- Ottmann, Oliver
An open prospective randomised multi-centre clinical evaluation to compare ALLEVYN gentle border with Mepilex border in the management of exuding chronic and acute wounds (22.04.2009 - 21.04.2011)
- Harding, Keith
AML 17 Supply agreement (29.04.2009 - 15.11.2019)
- Adams, Richard
Audit of effect of antifungal prophylaxis and enhanced diagnostics on the incidence and management of invasive fungal disease in high risk haematology and transplant recipients (01.06.2009 - 01.03.2010)
- Barnes, Rosemary
A combined genetic and small molecule approach to studying the role of the P38/MK2 stress signalling pathway in a human premature ageing syndrome (26.06.2009 - 26.12.2012)
- Kipling, David
A multi centre phase 3 cluster randomized controlled trial of a manualized anger management intervention for people with mild to moderate learning disabilities attending day services (01.07.2009 - 31.05.2012)
- Hood, Kerenza
A prospective, multi-centre, randomised, controlled clinical investigation of Dermagraft in patients with venous leg ulcers (01.08.2009 - 30.06.2011)
- Harding, Keith
A method for sampling wounds for exudate, enabling remote diagnosis of protease and other biological component activity in chronic wounds (01.09.2009 - 31.01.2012)
- Harding, Keith
A Randomised clinical trial for adults and children with acute myeloid leukaemia or high risk myelodysplastic syndrome - AML 17 (30.09.2009 - 31.03.2019)
- Ottmann, Oliver
Antibiotic resistance plasmids and their contribution to bacterial fitness and virulence (01.10.2009 - 30.09.2012)
- Walsh, Timothy
A preliminary, non-comparative study to evaluate a bioresorbable wound scaffold in acute wounds (01.10.2009 - 30.09.2010)
- Harding, Keith
A prospective pilot study of thigh administered intermittent pneumatic compression in the resolution and management of non-healing lower limb ulcers (01.10.2009 - 31.03.2011)
- Harding, Keith
A randomised phase II trial of carboplation and gemcitabane +/- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to receive cisplatin - TOUCAN (19.10.2009 - 30.09.2020)
- Adams, Richard
Artificially enhanced T-cells for targetting cancer (01.01.2010 - 31.01.2013)
- Sewell, Andrew
A prospective multi-centre, randomised, open-label parallel, comparative study to evaluate the effects of aquacel ag dressing and URGO-silver dressing on healing of chronic venous leg ulcers (15.01.2010 - 31.12.2010)
- Harding, Keith
A prospective study of bipolar disorder in pregnancy and the postpartum (20.01.2010 - 19.01.2013)
- Jones, Ian
A feasibility sutdy into Central Biotechnology Services (01.02.2010 - 30.05.2010)
- Topley, Nicholas
A tool for assessment of impulsivity (01.02.2010 - 31.01.2011)
- Morgan, Paul
Audit and research understanding across all specialist palliative care services to ensure all services are research aware (01.03.2010 - 31.03.2012)
All Wales Kidney Research Network (31.03.2010 - 31.03.2015)
- Fraser, Donald
A randomised phase II study of carboplatin with or without the addition of the ETAR inhibitor ZD4054 as treatment for patients with metastatic breast cancer (22.04.2010 - 30.06.2013)
A randomised phase II study of irinotecan, 5-flourouracil and folinic acid (FOLFIRI) with or without the addition of cediranib in the first line treatment of patients with metastatic colorectal cancer (22.04.2010 - 30.06.2013)
Amplification of IL-4Ra signalling pathways in human airways through 15LO1 (01.07.2010 - 30.06.2015)
- O'Donnell, Valerie
A prospective, multi-centre, randomised,longitudinal, cohort study of dermagraft in subjects with venous leg ulcers: A long-term followup to the DEVO-Trial (01.08.2010 - 31.01.2012)
- Harding, Keith
AML 16 being a National Cancer Research Institute Acute Myeloid Leukaemia and High Risk MDS Trial (06.08.2010 - 31.07.2013)
- Burnett, Alan
A pilot study to assess the effect of regulatory T cell depletion combined with vaccination in patients with colorectal cancer (01.10.2010 - 30.09.2013)
- Godkin, Andrew
An analysis of wild type human cytomegalovirus (01.12.2010 - 08.05.2014)
- Wilkinson, Gavin
Academic Fellowship Programme (01.01.2011 - 30.06.2011)
Analytical modelling work to inform the development of palliative care (09.02.2011 - 08.07.2011)
Acute myeloid leukaemia or high risk myelodysplastic syndrome multi-site randomised trial (27.02.2011 - 31.12.2011)
- Burnett, Alan
Accuracy testing of the chromosomal aberration and gene mutation markers of the AML profiler (01.03.2011 - 31.07.2013)
- Burnett, Alan
Antisocial behaviour in young people with ADHD: Identifying risk pathways (01.03.2011 - 30.11.2013)
- Thapar, Anita
ARCADE - Assessment of risk in chronic airway disease evaluation trial (01.03.2011 - 31.12.2016)
- Cockcroft, John
AML 18 pilot study (08.03.2011 - 28.02.2018)
- Ottmann, Oliver
Autophagy as a cell-autonomous mechanism of HIV control (22.03.2011 - 31.03.2014)
- Piguet, Vincent
ADAM15-mediated remodelling of the actin cytoskeleton in breast cancer cells (01.04.2011 - 31.03.2016)
- Poghosyan, Zaruhi
All Wales Perinatal Survey (01.04.2011 - 31.07.2018)
- Kotecha, Sailesh
A Phase III randomised, rater blinded study comparing two annual cycles of intravenous Alemtuzumab to three times weekly subcutaneous interferon beta 1a (Rebif) in treatment naive patients with relapsing-remitting multiple sclerosis (01.04.2011 - 31.03.2013)
- Robertson, Neil
A qualitative study exploring patients experience on the FRAGMATIC lung cancer trial (QUALFRAG) (01.05.2011 - 31.03.2014)
- Noble, Simon
AML 18 pilot (23.05.2011 - 22.11.2012)
- Burnett, Alan
-
- Burnett, Alan
Aquacel r Ag vs. Mepilex r border Ag- biourden study (01.06.2011 - 31.01.2012)
- Harding, Keith
Advise Pfizer on the results and clinical interpretation of the CONDOR (Celecoxib versus omeprazole and diclofenac for at-risk osteroarthritis and rheumatoid arthritis patients at increased gastrointestinal (G) risk trial (01.07.2011 - 30.11.2011)
- Choy, Ernest
An evaluation of the new medical statement "fit note": Analysis of fit note and sick note data (01.09.2011 - 01.02.2013)
- Cohen, Deborah
A randomised, double blind, placebo-controlled study of RAD001 (Everolimus) in the treatment of neurocognitive problems in tuberous sclerosis (01.09.2011 - 30.09.2018)
- Sampson, Julian
A single site, randomised, double blind, placebo-controlled clinical trial of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (01.09.2011 - 30.06.2020)
- Sampson, Julian
Antigenic ureaplasma variation and adaptation to ovineimmune response following experimental intrarauterin (01.10.2011 - 30.09.2016)
- Spiller, Brad
A prospective, multi-centre, non-comparative study to evaluate the safety and preliminary performance of the EASH dressing on chronic venous leg ulcers (01.10.2011 - 30.03.2012)
- Harding, Keith
AML 16 GZ evaluation (01.11.2011 - 30.03.2013)
- Hills, Robert
Analysis of population data on awareness and beliefs about ovarian cancer in Wales (01.11.2011 - 31.12.2012)
- Brain, Katherine
Analysis of plasma arsenic levels within NCRI AML 17 trial (21.11.2011 - 30.11.2016)
- Knapper, Steven
A programme of development for older patients with acute myeloid leukaemia and high risk myelodyspastic syndrome (01.03.2012 - 31.08.2013)
- Hills, Robert